All questions
Dosing and administration: Enhertu (fam-trastuzumab deruxtecan-nxki) in HR-positive HER2-low or HER2-ultralow breast cancer
1 question · 2 sources
Dosing and administration questions that apply to every indication of Enhertu are on Enhertu (fam-trastuzumab deruxtecan-nxki), all indications: Dosing and administration.
Dosing
What is the Enhertu dose for HER2-low breast cancer?
Note: Table 1 columns are indication, recommended ENHERTU dosage, and duration of therapy; the row shown covers HER2-low and HER2-ultralow metastatic breast cancer together with other indications that use the same monotherapy dose.